Header Logo

Connection

THOMAS A ALOIA to Survival Rate

Back to Details
This is a "connection" page, showing publications THOMAS A ALOIA has written about Survival Rate.
THOMAS A ALOIA
Connection Strength
1.549
Survival Rate
  1. Using Center-Specific Medicare Data to Compare Cancer Care Outcomes: Are We Seeing the Whole Playing Field or Just a Blade of Grass. Ann Surg Oncol. 2019 Nov; 26(12):3809-3810.
    View in: PubMed
    Score: 0.068
  2. Severe Preoperative Symptoms Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection. Ann Surg Oncol. 2019 Dec; 26(13):4548-4555.
    View in: PubMed
    Score: 0.068
  3. Detours on the Road to Recovery: What Factors Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection for Malignancy? J Gastrointest Surg. 2019 12; 23(12):2362-2371.
    View in: PubMed
    Score: 0.066
  4. Determining the Safety and Efficacy of Enhanced Recovery Protocols in Major Oncologic Surgery: An Institutional NSQIP Analysis. Ann Surg Oncol. 2019 Mar; 26(3):782-790.
    View in: PubMed
    Score: 0.065
  5. Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma. J Gastrointest Surg. 2016 Apr; 20(4):741-7.
    View in: PubMed
    Score: 0.053
  6. Advances in hepatectomy technique: Toward zero transfusions in the modern era of liver surgery. Surgery. 2016 Mar; 159(3):793-801.
    View in: PubMed
    Score: 0.052
  7. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014 Aug; 110(2):107-14.
    View in: PubMed
    Score: 0.047
  8. Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome. Surgery. 2012 Jun; 151(6):851-9.
    View in: PubMed
    Score: 0.040
  9. Management of colorectal liver metastases: past, present, and future. Updates Surg. 2011 Mar; 63(1):1-3.
    View in: PubMed
    Score: 0.038
  10. A decision analysis model predicts the optimal treatment pathway for patients with colorectal cancer and resectable synchronous liver metastases. Clin Colorectal Cancer. 2008 May; 7(3):197-201.
    View in: PubMed
    Score: 0.031
  11. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg. 2008 Jan; 12(1):117-22.
    View in: PubMed
    Score: 0.030
  12. Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005. J Gastrointest Surg. 2008 Jan; 12(1):110-6.
    View in: PubMed
    Score: 0.030
  13. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg. 2006 Dec; 244(6):897-907; discussion 907-8.
    View in: PubMed
    Score: 0.028
  14. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006 May; 141(5):460-6; discussion 466-7.
    View in: PubMed
    Score: 0.027
  15. Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response. Arch Surg. 2005 Nov; 140(11):1115-20.
    View in: PubMed
    Score: 0.026
  16. Management of early-stage cutaneous melanoma. Curr Probl Surg. 2005 Jul; 42(7):460-534.
    View in: PubMed
    Score: 0.026
  17. Survival by Number and Sites of Resections of Recurrence after First Curative Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2022 12; 26(12):2503-2511.
    View in: PubMed
    Score: 0.021
  18. Improved Survival over Time After Resection of Colorectal Liver Metastases and Clinical Impact of Multigene Alteration Testing in Patients with Metastatic Colorectal Cancer. J Gastrointest Surg. 2022 03; 26(3):583-593.
    View in: PubMed
    Score: 0.020
  19. Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis. Ann Surg Oncol. 2021 Mar; 28(3):1457-1465.
    View in: PubMed
    Score: 0.019
  20. RAS/TP53 Co-mutation is Associated With Worse Survival After Concurrent Resection of Colorectal Liver Metastases and Extrahepatic Disease. Ann Surg. 2022 08 01; 276(2):357-362.
    View in: PubMed
    Score: 0.019
  21. APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases. Ann Surg. 2020 12; 272(6):1080-1085.
    View in: PubMed
    Score: 0.019
  22. Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2021 01; 25(1):186-194.
    View in: PubMed
    Score: 0.019
  23. A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status. J Natl Compr Canc Netw. 2020 11; 18(11):1500-1508.
    View in: PubMed
    Score: 0.018
  24. Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes. Eur J Surg Oncol. 2020 09; 46(9):1588-1595.
    View in: PubMed
    Score: 0.018
  25. Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation. J Gastrointest Surg. 2020 05; 24(5):1033-1039.
    View in: PubMed
    Score: 0.018
  26. Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma? HPB (Oxford). 2020 04; 22(4):545-552.
    View in: PubMed
    Score: 0.017
  27. Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases. Clin Cancer Res. 2019 10 01; 25(19):5843-5851.
    View in: PubMed
    Score: 0.017
  28. Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation. J Am Coll Surg. 2019 09; 229(3):286-294.e1.
    View in: PubMed
    Score: 0.017
  29. Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases. Ann Surg. 2019 05; 269(5):917-923.
    View in: PubMed
    Score: 0.017
  30. RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg. 2019 01; 269(1):120-126.
    View in: PubMed
    Score: 0.016
  31. Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2019 Jan; 26(1):275-281.
    View in: PubMed
    Score: 0.016
  32. The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma. Am J Surg. 2019 07; 218(1):145-150.
    View in: PubMed
    Score: 0.016
  33. Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival. J Gastrointest Surg. 2019 01; 23(1):84-92.
    View in: PubMed
    Score: 0.016
  34. Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases. Ann Surg Oncol. 2018 Jun; 25(6):1709-1715.
    View in: PubMed
    Score: 0.015
  35. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol. 2018 05; 44(5):684-692.
    View in: PubMed
    Score: 0.015
  36. Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases. Ann Surg. 2018 03; 267(3):514-520.
    View in: PubMed
    Score: 0.015
  37. Two-Stage Hepatectomy vs One-Stage Major Hepatectomy with Contralateral Resection or Ablation for Advanced Bilobar Colorectal Liver Metastases. J Am Coll Surg. 2018 05; 226(5):825-834.
    View in: PubMed
    Score: 0.015
  38. Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases. J Vasc Interv Radiol. 2018 03; 29(3):395-403.e1.
    View in: PubMed
    Score: 0.015
  39. Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter? Ann Surg Oncol. 2018 Jan; 25(1):179-187.
    View in: PubMed
    Score: 0.015
  40. Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases. JAMA Surg. 2017 Oct 18; 152(10):e172986.
    View in: PubMed
    Score: 0.015
  41. Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases. Ann Surg Oncol. 2017 Dec; 24(13):3857-3864.
    View in: PubMed
    Score: 0.015
  42. Long term outcome after resection of liver metastases from squamous cell carcinoma. Eur J Surg Oncol. 2017 Nov; 43(11):2129-2134.
    View in: PubMed
    Score: 0.015
  43. Extended Lymphadenectomy Is Required for Incidental Gallbladder Cancer Independent of Cystic Duct Lymph Node Status. J Gastrointest Surg. 2018 01; 22(1):43-51.
    View in: PubMed
    Score: 0.015
  44. Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma. Surgery. 2017 10; 162(4):752-765.
    View in: PubMed
    Score: 0.015
  45. Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High- and Low-Incidence Countries. Ann Surg Oncol. 2017 Aug; 24(8):2334-2343.
    View in: PubMed
    Score: 0.014
  46. Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater. Ann Surg Oncol. 2017 Jul; 24(7):2031-2039.
    View in: PubMed
    Score: 0.014
  47. Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma. Cancer. 2017 05 15; 123(10):1817-1827.
    View in: PubMed
    Score: 0.014
  48. Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection. J Gastrointest Surg. 2017 04; 21(4):628-635.
    View in: PubMed
    Score: 0.014
  49. Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. J Surg Oncol. 2017 Feb; 115(2):144-150.
    View in: PubMed
    Score: 0.014
  50. Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection. Surgery. 2017 03; 161(3):753-759.
    View in: PubMed
    Score: 0.014
  51. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2016 08; 23(8):2635-43.
    View in: PubMed
    Score: 0.013
  52. Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival. Ann Surg. 2016 Jan; 263(1):146-52.
    View in: PubMed
    Score: 0.013
  53. The Impact of Postoperative Complications on a Timely Return to Intended Oncologic Therapy (RIOT): the Role of Enhanced Recovery in the Cancer Journey. Int Anesthesiol Clin. 2016; 54(4):e33-46.
    View in: PubMed
    Score: 0.013
  54. Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2016 Mar; 23(3):1003-11.
    View in: PubMed
    Score: 0.013
  55. Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis. J Clin Oncol. 2016 Jan 20; 34(3):219-26.
    View in: PubMed
    Score: 0.013
  56. Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients. J Gastrointest Surg. 2015 Aug; 19(8):1476-83.
    View in: PubMed
    Score: 0.013
  57. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg. 2015 Apr; 261(4):733-9.
    View in: PubMed
    Score: 0.013
  58. Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. Ann Surg Oncol. 2015 Jul; 22(7):2416-23.
    View in: PubMed
    Score: 0.012
  59. Is complete liver resection without resection of synchronous lung metastases justified? Ann Surg Oncol. 2015 May; 22(5):1585-92.
    View in: PubMed
    Score: 0.012
  60. RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases. Ann Surg Oncol. 2015 Mar; 22(3):834-842.
    View in: PubMed
    Score: 0.012
  61. Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates? J Gastrointest Surg. 2015 Jan; 19(1):80-6; discussion 86-7.
    View in: PubMed
    Score: 0.012
  62. Morbidity and mortality in 1,174 patients undergoing hepatic parenchymal transection using a stapler device. Ann Surg Oncol. 2014 Mar; 21(3):995-1001.
    View in: PubMed
    Score: 0.011
  63. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. J Gastrointest Surg. 2014 Feb; 18(2):269-78; discussion 278.
    View in: PubMed
    Score: 0.011
  64. Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma. Oncology. 2013; 85(4):197-203.
    View in: PubMed
    Score: 0.011
  65. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013 Jun; 257(6):1079-88.
    View in: PubMed
    Score: 0.011
  66. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg. 2013 Feb; 216(2):201-9.
    View in: PubMed
    Score: 0.011
  67. Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors. Ann Surg Oncol. 2013 Apr; 20(4):1223-9.
    View in: PubMed
    Score: 0.011
  68. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012 Dec 20; 30(36):4566-72.
    View in: PubMed
    Score: 0.011
  69. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg. 2013 Jan; 17(1):66-77; discussion p.77.
    View in: PubMed
    Score: 0.011
  70. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90.
    View in: PubMed
    Score: 0.010
  71. Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol. 2011 Oct 10; 29(29):3892-9.
    View in: PubMed
    Score: 0.010
  72. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford). 2011 Nov; 13(11):774-82.
    View in: PubMed
    Score: 0.010
  73. Can hepatocellular cancer screening increase the proportion of long-term survivors? Hepatogastroenterology. 2009 Jul-Aug; 56(93):1152-6.
    View in: PubMed
    Score: 0.008
  74. Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery? Arch Surg. 2008 Jun; 143(6):538-43; discussion 543.
    View in: PubMed
    Score: 0.008
  75. Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT). Ann Surg. 2007 Aug; 246(2):301-10.
    View in: PubMed
    Score: 0.007
  76. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant. 2007 Sep; 7(9):2165-71.
    View in: PubMed
    Score: 0.007
  77. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg. 2006 Oct; 244(4):524-35.
    View in: PubMed
    Score: 0.007
  78. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol. 2006 May; 13(5):712-20.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.